Nalaganje...
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes
We are currently in the middle of a major shift in biomedical research: unprecedented and rapidly growing amounts of data may be obtained today, from in vitro, in vivo and clinical studies, at molecular, physiological and clinical levels. To make use of these large-scale, multi-level datasets, corre...
Shranjeno v:
| izdano v: | Interface Focus |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Royal Society
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4759745/ https://ncbi.nlm.nih.gov/pubmed/27051506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsfs.2015.0075 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|